Omega-3 fatty acid supplements linked to a higher AFib risk, new meta-analysis confirms

Anthony Vecchione | | Cardiovascular Business | Heart Rhythm
Fish oil supplements are used to reduce cardiovascular disease risk, but can actually increase the risk of atrial fibrillation in some patients.

Regularly taking Omega-3 fatty acid supplements — fish oil supplements, for example — have been linked to certain cardiovascular benefits. However, according to a new meta-analysis published in Circulation, they also increase a person's risk of atrial fibrillation (AFib).

The team tracked data from 81,210 patients who participated in one of seven trials from January 2012 to December 2020. Thirty-nine percent of patients were women, and the mean patient age was 65 years old. The weighted median follow-up was 4.9 years.

While 72.6% of patients were enrolled in trials that tested a lower dose of one gram or less per day, the remaining patients were enrolled in trials that tested doses of more than one gram per day.

Overall, the team reported, the use of marine omega-3 fatty acid supplements was associated with an increased risk of AFib. In addition, the risk appears to increase as the daily dose of these supplements increases. 

In addition, in analyses ranked by dose, the hazard ratio (HR) was greater in the trials testing >1g/d  compared with those testing ≤1 g/d.

“This meta-analysis adds new evidence regarding the risk of AFib in patients taking marine omega-3 fatty acid supplements,” wrote lead author Baris Gencer, MD, MPH, with the cardiology division at Geneva University Hospitals in Switzerland, and colleagues. “The potential risk of developing AFib should be discussed with the patients when prescribing marine omega-3 supplementation, especially when prescribing a higher dosage.”

Gencer et al. noted that post-marketing surveillance for AFib in combination with systematic ascertainment of AFib outcomes in future trials of marine omega-3 supplementation is recommended as a way to better define the risk-benefit ratio across omega-3 formulations.

Read the full study here.

 

Related fish oil content:

Fish oil supplements linked to potentially fatal heart rhythm issues

Fish oil supplements lower the risk of heart disease — but only for patients with the right genetic makeup

Fish oil and vitamin D supplements don’t prevent atrial fibrillation

Latest fish oil analysis suggests omega-3s promote heart health

Fish oil supplements linked to potentially fatal heart rhythm issues

 

Anthony Vecchione

Related Content

LAAC with Watchman FLX reduces bleeding risks after AFib ablation
Eko Health’s AI platform for digital stethoscopes granted new CPT code
Predicting sudden cardiac death after a heart attack may be impossible—for now
Concomitant ablation surgery during heart operations boosts long-term survival
Johnson & Johnson MedTech gains FDA approval for Varipulse PFA system
Boston Scientific agrees to acquire AFib ablation company

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business
What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."